About
Technology
Issues
FAQ
Links
Official Page
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.